Latest news
Loading news…
Merus discovers and develops new treatments for cancer using the Multiclonics Platform.
Merus was acquired by Genmab in 2025 for $8B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
227
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Utrecht, The Netherlands
227
professional contacts at Merus
Contact execs at Merus →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Merus
Loading news…
FAQs about Merus
People who checked this page also checked these
Browse the full Acquirezy directory.